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Yeast cells contain a family of three monothiol glutaredoxins: Grx3, 4, and 5. Absence of Grx5
leads to constitutive oxidative damage, exacerbating that caused by external oxidants. Phenotypic
defects associated with the absence of Grx5 are suppressed by overexpression of SSQ1 and ISA2,
two genes involved in the synthesis and assembly of iron/sulfur clusters into proteins. Grx5
localizes at the mitochondrial matrix, like other proteins involved in the synthesis of these clusters,
and the mature form lacks the first 29 amino acids of the translation product. Absence of Grx5
causes: 1) iron accumulation in the cell, which in turn could promote oxidative damage, and 2)
inactivation of enzymes requiring iron/sulfur clusters for their activity. Reduction of iron levels
in grx5 null mutants does not restore the activity of iron/sulfur enzymes, and cell growth defects
are not suppressed in anaerobiosis or in the presence of disulfide reductants. Hence, Grx5 forms
part of the mitochondrial machinery involved in the synthesis and assembly of iron/sulfur
centers.
INTRODUCTION
Glutaredoxins and thioredoxins are thioloxidoreductases re-
quired for maintaining thiol/disulfide equilibrium in cell
proteins (Holmgren, 1989; Carmel-Harel and Storz, 2000;
Grant, 2001) and also for the activity of specific enzymes
(Aslund et al., 1994; Lillig et al., 1999). Glutaredoxin requires
the reduced form of glutathione (GSH) as an electron donor
(Holmgren and Aslund, 1995). In Saccharomyces cerevisiae,
five glutaredoxins have been identified. Grx1 and Grx2 have
two cysteine residues each at their active sites and play
different roles in protecting cells against oxidants such as
hydrogen peroxide and menadione (Luikenhuis et al., 1998).
The defensive roles of Grx1 and Grx2 may overlap with
those of the cytosolic Trx1 and Trx2 thioredoxins: at least
one Grx1/Grx2 glutaredoxin or Trx1/Trx2 thioredoxin is
required for yeast cell viability (Draculic et al., 2000). An-
other mitochondrial thioredoxin, Trx3, has been described in
S. cerevisiae (Pedrajas et al., 1999). Besides Grx1 and Grx2,
yeast cells have three monocysteine glutaredoxins: Grx3,
Grx4, and Grx5 (Rodrı´guez-Manzaneque et al., 1999). The
absence of Grx3 or Grx4 does not have a dramatic effect on
sensitivity to oxidants. In contrast, the absence of Grx5 re-
sults in high sensitivity to hydrogen peroxide and menadi-
one, increased protein oxidative damage, growth defects in
minimal medium, and inability for respiratory growth (Ro-
drı´guez-Manzaneque et al., 1999). The Grx3, Grx4, and Grx5
proteins have been included in a large protein superfamily
that contains a conserved structural domain (from amino
acids 46–132 in Grx5) defined after the human PICOT pro-
tein (Isakov et al., 2000). PICOT may play a negative regu-
latory role in protein kinase C-mediated activation of the
transcription factors AP-1 and NF-B in human cells (Witte
et al., 2000). The N-terminal extension of Grx3 and Grx4 (not
present in Grx5) shares additional sequence homology with
the N-terminal moiety of human PICOT and other members
of the superfamily (Isakov et al., 2000; Rahlfs et al., 2001).
Respiratory growth defects of grx5 mutant cells suggest
impairment of mitochondrial functions. One of the essential
processes occurring in the mitochondrial matrix of yeast
cells is the generation of iron/sulfur (Fe/S) clusters, which
are assembled in proteins destined to mitochondrial, cyto-
solic, or nuclear compartments (Craig et al., 1999; Lill et al.,
1999; Lill and Kispal, 2000). These clusters are especially
sensitive to oxidants (Keyer and Imlay, 1996) and liberate
free iron that could further reactive oxygen species (ROS)
production (Cadenas, 1989). Biogenesis of Fe/S clusters is a
conserved process from bacteria to higher eukaryotes (Lill et
al., 1999; Lill and Kispal, 2000), although in humans biosyn-
thetic complexes for Fe/S cluster assembly are also found in
the cytosol (Tong and Rouault, 2000). In S. cerevisiae, synthe-
sis and assembly of Fe/S clusters involves Nfs1 cysteine
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desulfurase (Kispal et al., 1999; Li et al., 1999), the ferric
ion-binding proteins Isu1 and Isu2 (Garland et al., 1999;
Schilke et al., 1999), the Yah1 ferrodoxin (Barros and No-
brega, 1999; Lange et al., 2000), the Arh1 ferrodoxin reduc-
tase (Lacour et al., 1998; Manzella et al., 1998), the molecular
chaperones Ssq1 (Hsp70-type) and Jac1 (Hsp40 or J-type;
Schilke et al., 1996; Strain et al., 1998; Schilke et al., 1999; Lutz
et al., 2001; Voisine et al., 2001), the homologous proteins Isa1
and Isa2 (Jensen and Culotta, 2000; Kaut et al., 2000; Pelzer et
al., 2000), and the functionally uncharacterized protein Nfu1
(Schilke et al., 1999). Exporting Fe/S for extramitochondrial
proteins requires the mitochondrial ABC transporter Atm1
(Kispal et al., 1999). Mutations in yeast genes involved in
Fe/S cluster assembly cause iron accumulation in the mito-
chondria, mitochondrial DNA damage, and respiratory me-
tabolism failure (Craig et al., 1999; Lill and Kispal, 2000).
Similar phenotypes are observed in null mutants for YFH1
(Babcock et al., 1997; Foury and Cazzalini, 1997), the yeast
homologue for the human frataxin gene, with a possible role
in mitochondrial iron homeostasis (Foury, 1999; Radisky et
al., 1999; although other functions have also been suggested
for YFH1 [Ristow et al., 2000]). All of these observations
suggest a relationship among Fe/S cluster biogenesis, mito-
chondrial metal homeostasis, and oxidative damage.
In this work we demonstrate that Grx5 is a mitochondrial
glutaredoxin required for the activity of Fe/S-containing
enzymes and that its absence affects iron homeostasis and
causes osmotic stress at the cell.
MATERIALS AND METHODS
Yeast Strains and Plasmids
The yeast strains are described in Table 1. The following plasmids
contain the genes indicated in parenthesis plus their own promoter
and terminator sequences (without adjacent complete open reading
frames [ORFs]) cloned in the multicopy vector Yeplac181 (Gietz and
Sugino, 1988): pMM62 (GRX5), pMM70 (SSQ1), pMM72 (ISA1), and
pMM74 (ISA2). Plasmids pCM316, pCM317, and pCM318 contain
the complete GRX4, GRX3, and GRX5 ORFs, respectively (without
further sequences), cloned in the multiple cloning site of pCM190
(Garı´ et al., 1997) under the control of the doxycycline-regulated
tetO7 promoter. pMM54 is a YIplac128 (Gietz and Sugino, 1988)
derivative with GRX5 under its own promoter, tagged at the 3-end
with three hemagglutinin (HA) epitopes in tandem. pMM117 is a
derivative of YIplac211 (Gietz and Sugino, 1988) containing the
doxycycline-regulated tTA activator (Garı´ et al., 1997) and the GRX5
ORF (plus terminator sequences) under the control of the tetO7
promoter.
Growth Conditions and Determination of Cell
Parameters
Cells were grown at 30°C in YPD, YPG (as YPD but with 3% glycerol
instead of dextrose), SD medium (0.67% yeast nitrogen base, 2%
glucose, and auxotrophic requirements), or SC medium (the same as
SD plus drop-out mixture [Kaiser et al., 1994 ]). Specific supplements
were omitted from the SC medium when required. For growth in
anaerobic conditions, inoculated plates were incubated in an anaer-
obiosis chamber. Cell numbers (in formaldehyde-fixed samples)
and mean cell volumes were determined in a Coulter Z2 counter
(Beckman Coulter, Fullerton, CA). 4,6-Diamidino-2-phenylindole
staining was done as described by Kaiser et al. (1994).
Gene Disruptions and Other Genetic Methods
Standard methods were used for DNA manipulation, transforma-
tion, crosses between yeast strains, sporulation, and tetrad analyses.
SC medium with appropriate supplements was used to select trans-
formants on grx5 mutant cells. The wild-type GRX5 allele was
disrupted in the W303 background using the kanMX4 cassette, as
previously described (Rodrı´guez-Manzaneque et al., 1999). A similar
approach was used to construct a null mutant in TRX3, using a
Table 1. Strains used in this work
Strain Relevant phenotype Comments
CML235 MATa ura3-52 leu21 his3200 Wild type (Rodriguez-Manzaneque et al., 1999)
CML236 As CML235 but MAT Wild type
MML19 MATa grx5kanMX4 Deletion of GRX5 in CML235
MML246 MATa/MAT GRX5/grx5kanMX4 Diploid from a cross CML236  MML19
MML248 MATa/MAT GRX5/grx5kanMX4 trx3CaURA3 Deletion of TRX3 in MML246
MML264 MATa grx5kanMX4 trx3CaURA3 Spore from MML248
W303-1A MATa ura3-1 ade2-1 leu2-3,112 trp1-1 his3-11,15 Wild type
W303-1B As W303-1B but MAT Wild type
MML100 MATa grx5kanMX4 Deletion of GRX5 in W303-1A
MML235 MAT [pMM54(GRX5-3HA)]LEU2 Integration of linear pMM54 in W303-1B
MML240 MATa grx5kanMX4 [pMM54(GRX5-3HA)]LEU2 Spore from a cross MML100  MML235
MML266 MAT [pMM96(grx5-8-3HA)]LEU2 Integration of linear pMM96 in W303-1B
MML271 MAT (pMM98[grx5-23-3HA])LEU2 Integration of linear pMM98 in W303-1B
MML289 MAT grx5kanMX4 Spore from a cross W303-1B  MML100
MML290 MATa grx5kanMX4 (pMM96 [grx5-8-3HA])LEU2 Spore from a cross MML100  MML266
MML298 MATa yfhkanMX4 Spore from a cross MML100  MML281
MML300 MATa yfhkanMX4 grx5kanMX4 Spore from a cross MML100  MML281
MML312 MATa (pMM117[tTA tetO-GRX5])URA3 tetR-Ssn6LEU2 Integration of linear pMM117 in CML240 (Belli et al., 1998)
MML313 MATa grx5kanMX4 (pMM117[tTA tetO-GRX5])URA3
tetR-Ssn6LEU2
Spore from a cross MML289  MML312
MML345 MATa aft1-5URA3 grx5kanMX4 Spore from a cross W303-1B  MML348
MML348 MATa aft1-5URA3 Several backcrosses from CML126 (Casas et al., 1997) to
introduce the aft1-5 mutation in the W303 background
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polymerase chain reaction-amplified cassette with the CaURA3
marker from pAG60 (Goldstein et al., 1999). Oligonucleotides for
amplification of the disruptant cassettes were designed to disrupt
most of the targeted gene upon transformation with the amplified
DNA.
Isolation of grx5 Suppressors
Exponentially growing MML19 cells were transformed with a yeast
genomic DNA library in the multicopy plasmid YEp13. The trans-
formation mixture was then plated on SD agar plates, which were
incubated for 6 d at 30°C. Wild-type CML235 cells were transformed
in parallel as a control to quantify transformation efficiency. Two
independent transformation experiments were carried out with
60,000 transformants on wild-type cells. Plasmids were recovered
from growing grx5 transformants, amplified in Escherichia coli, and
retransformed on MML19 cells to confirm their ability to suppress
the transformation defect of grx5 mutants. Finally, we recovered
nine plasmids that gave stable transformation on grx5 cells. Restric-
tion fragment analysis and hybridization with a GRX5 probe dem-
onstrated that the plasmids corresponded to four different clones.
One (three separate isolates) contained GRX5, and the other three
clones contained inserts from other chromosomal locations: pMM44
(one isolate), pMM45 (two isolates), and pMM46 (three isolates).
Partial sequencing of insert ends was carried out to reveal the genes
included in each suppressor plasmid.
Construction of GRX5 Derivatives with Deletions
at the Mitochondrial Targeting Sequence
Plasmid pMM54 (GRX5-3HA) was used as a template to generate
two constructions with deletions in the GRX5 coding sequence,
using the ExSite approach (Weiner and Costa, 1995). The resulting
pMM96 plasmid contains a deletion that spans from base pairs 4
to 27 (grx5-8), and pMM98 has a deletion spanning from base
pairs 4 to 72 (grx5-23). Linearized (EcoRV digestion) plasmids
pMM96 and pMM97 were stably integrated at the chromosomal
LEU2 locus of W303–1B cells and generated strains MML266 and
MML271, respectively.
Sensitivity to Menadione
Cells growing exponentially in YPD medium at 30°C (2  107
cells/ml) were added with menadione. Plasmid-transformed cul-
tures were grown in SD medium in selective conditions. In this case,
cells were transferred to YPD medium for 4 h before sensitivity
analyses. After various treatment times, 1:5 serial dilutions were
made, and drops were spotted onto YPD plates. Growth was re-
corded after 2 d of incubation at 30°C.
Western Blot Analyses
Western blot analyses were done according to the method of Bellı´ et
al. (1998). 12CA5 anti-HA mAb (Roche Diagnostics, Mannheim,
Germany) was used at a 1:5000 dilution. An anti-lipoic acid anti-
body was used at a 1:50,000 dilution to detect protein-bound lipoic
acid (Cabiscol et al., 2000). Anti-Aco1 aconitase (1:2000 dilution,
from R. Lill), anti-succinate dehydrogenase (1:1000 dilution, from B.
Lemire), and anti-cytochrome b2 (1:1000 dilution, from E. Valentı´n)
antibodies were also used.
Isolation of Mitochondrial Fractions
Mitochondria were purified as described by Luttik et al. (1998).
Zymolyase 20T (ICN Biochemicals, Cleveland, OH) was used at 3
mg/g of cells (dry weight). Spheroplasts were broken (eight strokes)
with a Dounce homogenizer. Mitochondria (pellet) were separated
from the postmitochondrial (supernatant) fraction, resuspended in a
hypotonic solution (20 mM HEPES plus 1 mM phenylmethylsulfo-
nyl fluoride), and centrifuged in a microfuge (12,000 rpm, 10 min) at
0°C. The resulting pellet and supernatant were respectively consid-
ered as the intermembrane space and matrix fractions.
Identification of the Signal Peptide Cleavage Site
for Grx5
Four grams of cells grown in YPG medium were resuspended in 50
mM Tris buffer, pH 7.5, plus 20 mM NaCl and disrupted in a French
Press (SLM Aminco). After centrifugation (12,000 rpm, 30 min), the
crude supernatant was applied to an ionic exchange column (DEAE
15HR, Waters, Milford, MA). Proteins were eluted with a linear
gradient (20–400 mM NaCl in Tris-HCl buffer, pH 7.5), and frac-
tions containing Grx5 were identified by Western blot using specific
polyclonal antibodies. Proteins in the fractions were separated by
two-dimensional electrophoresis. First dimension was performed in
a Protean Isoelectric Focusing Cell (Bio-Rad, Hercules, CA) using
17-cm IPG strips (Bio-Rad Ready Strip, pH range 3–11). Second
dimension was performed according to the denaturing discontinu-
ous buffer system of Laemmli. Proteins were transferred to a poly-
vinylidene difluoride membrane using a semidry system, and the
spot corresponding to Grx5 (identified by Western blot in a dupli-
cate membrane with the above antibodies) was N-terminal se-
quenced by Edman degradation using a Beckman LF3000 sequencer
equipped with a phenylthiohydantoin derivative analyzer (System
Gold, Beckman).
Other Methods
Analysis of protein carbonylation after derivatization of carbonyl
groups with dinitrophenylhydrazine was carried out as described
by Cabiscol et al. (2000). Enzymatic activities were assayed by the
following standard methods: aconitase, citrate synthase, malate de-
hydrogenase (Robinson et al., 1987), and succinate dehydrogenase
(Munujos et al., 1993). Activities were expressed in units (nanomoles
per minute) per milligram of cell protein. Extracts were prepared in
0.1 M Tris buffer, pH 8.1, plus 2 mM EDTA using glass beads to
disrupt the cells. Nonmitochondrial citrate synthase is not stable at
this pH (Liao et al., 1991). Whole cell and mitochondrial iron were
determined under reducing conditions (Fish, 1988), with batho-
phenanthroline sulfonate (BPS) as chelator and after acid digestion
of cells or mitochondria with 3% nitric acid. Mitochondrial and
postmitochondrial iron were also determined according to the
method of Tangeras et al. (1980) after incubation of the samples with
10 mM 2-(N-morpholino)ethanesulfonic acid-KOH buffer, pH 4.5,
plus 1% SDS (1 h, 95°C). No significant differences were observed
among results with both methods. Heme covalently bound to cyto-
chrome c was detected as described by Vargas et al. (1993), using the
Supersignal detection system (Pierce Chemical, Indianapolis, IN).
To purify yeast Grx5 glutaredoxin, the entire GRX5 ORF was cloned
in-frame in pGEX-4T1 (Amersham Pharmacia Biotech, Piscataway,
NJ) to generate a GSH S-transferase (GST)-Grx5 fusion protein. The
construct was expressed in E. coli cells. GST-Grx5 was purified from
bacterial cell extracts using GSH-Sepharose 4B columns (Amersham
Pharmacia). After thrombin cleavage, Grx5 was separated from GST
and contaminants by preparative electrophoresis, using a Bio-Rad
491 PrepCell. Polyclonal anti-Grx5 antibodies were raised in rabbits
and purified from rabbit serum in a protein A-Sepharose CL-4B
column (Amersham Pharmacia).
RESULTS
Defects in grx5 Mutants Are Suppressed by Genes
Involved in Fe/S Cluster Assembly
Given the defective growth phenotype of null grx5 mutants
in minimal SD medium, we isolated transformants (on
MML19 cells) from a multicopy genomic DNA library that
were able to grow in such conditions. Three different clones,
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whose inserts were characterized by DNA sequencing, were
redundantly isolated in two independent experiments. Plas-
mid pMM44 contains two complete ORFs, SSQ1 and ARC18.
Plasmid pMM45 contains ROX1, UBA3, ISA2, HOS1, and
SPE3, and pMM46 contains RPS22B, YLR368w, SSQ1, and
ARC18. We focused our attention on SSQ1 and ISA2, two
genes involved in Fe/S cluster assembly at the mitochondria
(see INTRODUCTION). To confirm that SSQ1 and ISA2
were really suppressors of grx5 defects, both genes and their
respective promoter and terminator sequences were cloned
in the multicopy plasmid YEplac181 and then used to trans-
form a grx5 null mutant. This mutant was also transformed
with a construction carrying GRX5 under its own promoter
in YEplac181. Transformants were obtained in all three cases
(50% transformation efficiency for SSQ1 and 30% for ISA2
relative to GRX5). Multicopy plasmids containing SSQ1 or
ISA2 allowed grx5 cell growth in SD medium (Figure 1A,
left). In addition, the SSQ1 plasmid suppressed better the
sensitivity of grx5 cells to menadione than did the ISA2
plasmid (Figure 1A, right). Although ISA2 is highly homol-
ogous in sequence to ISA1, overexpression of the latter was
not capable of suppressing the grx5 phenotypes (Rodrı´guez-
Manzaneque, Tamarit, Bellı´, Ros, and Herrero, unpublished
results). We therefore conclude that, when overexpressed,
some (but not all) of the genes involved in the Fe/S cluster
assembly are capable of counteracting the absence of GRX5.
This suggests a functional relationship between Grx5 glu-
taredoxin and Fe/S cluster assembly at the mitochondria. As
with mutants in the Fe/S assembly machinery and with
yeast frataxin mutants (Babcock et al., 1997; Jensen and Cu-
lotta, 2000; Kaut et al., 2000), grx5 cells are unable to use
glycerol as a sole carbon source (Rodrı´guez-Manzaneque et
al., 1999). In contrast with other phenotypes shown in Figure
1A, grx5 cell respiratory ability was not directly rescued by
transformation with the GRX5 gene. To the contrary, a plas-
mid carrying GRX5 only rescued growth ability on glycerol
in a chromosomal grx5 background after this mutant had
been crossed with wild-type cells transformed with the
GRX5 plasmid, followed by sporulation of the resulting
diploid. This is consistent with grx5 cells having extensively
accumulated mutations in mitochondrial DNA, thereby
causing the respiratory defect.
Figure 1. Suppression of phenotypic
defects of null grx5 mutants. (A)
CML235 wild-type (GRX5) cells and
MML19 (grx5) cells nontransformed
or transformed with the multicopy
plasmids pMM62 (GRX5), pMM70
(SSQ1), or pMM74 (ISA2) were tested
for growth on SD medium plates (left)
and for sensitivity to 10 mM menadi-
one (Md) treatment at 30°C (right).
Serial dilutions of exponential cul-
tures (treated with menadione for the
indicated times) were plated on YPD
plates. (B) CML235 and MML19 cells
transformed with the pCM190 (tetO7
promoter)-derived plasmids pCM317
(GRX3), pCM316 (GRX4), or pCM318
(GRX5) were tested for growth on SD
medium plates (left) and for menadi-
one sensitivity (right) in overexpres-
sion conditions (minus doxycycline).
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We also tested whether GRX3 or GRX4 (the other two
members of the same gene family) suppressed the pheno-
types of a grx5 mutant when overexpressed from the doxy-
cycline-regulatable tet promoter (Garı´ et al., 1997). Grx3 and
Grx4 only slightly overcame the sensitivity to menadione or
the growth defect in SD medium of cells deficient in Grx5
(Figure 1B), suggesting that Grx5 performs different func-
tions from the other two members of the family.
Grx5 Is a Mitochondrial Glutaredoxin
Genetic interactions between Grx5 and mitochondrial proteins
implicated in the biogenesis and protein assembly of Fe/S
clusters suggested that Grx5 could be a mitochondrial glutare-
doxin. PSORT analysis predicts a mitochondrial location for
Grx5 due to mitochondrial targeting signatures at its N-
terminal region (Pon and Schatz, 1991). To confirm this, we
raised antibodies against Grx5 protein that had been ex-
pressed in E. coli and then purified. We used these antibod-
ies to purify the mature form of the overexpressed (from the
tet promoter) Grx5 protein in S. cerevisiae. N terminus se-
quencing of the protein spot isolated from a two-dimen-
sional gel showed that mature Grx5 begins with the se-
quence LSTEIRKA. Hence, the mature product lacks the first
29 amino acids predicted from the proposed GRX5 ORF
(Figure 2A). Remarkably, GRX3 and GRX4 sequences have
no homology with these N-terminal Grx5 residues (Rodrı´-
Figure 2. Grx5 is a mitochondrial glu-
taredoxin. (A) N terminus Grx5 amino
acid sequence. Arrow marks where the
precursor form is processed, as deter-
mined by N terminus sequencing of
mature Grx5. The length of the two
constructed signal peptide deletions
(Grx5-8 and Grx5-23) is indicated.
(B) Western blot immunodetection of
3HA-tagged Grx5 in extracts from ex-
ponential cultures of MML240 cells in
YPD and YPG medium at 30°C and in
YPD medium plus menadione (Md, 30
min). Left lane (control) corresponds to
W303–1A cell extracts. The same
amount of total cell protein (40 g) was
run in each lane. (C) MML235 and
MML266 (Grx5-8) cells grown expo-
nentially in YPG medium at 30°C were
fractionated, and the resulting frac-
tions were analyzed by Western blot.
Anti-HA antibodies were used to de-
tect Grx5 (MML235 fractions) and
Grx5-8 (MML266 fractions), and anti-
lipoic acid antibodies were used to de-
tect the matrix markers pyruvate dehy-
drogenase (PDH) and -ketoglutarate
dehydrogenase (-KGDH). Cyto-
chrome b2 (cyt b2) was used as an in-
termembrane space (IMS) marker. Re-
sults for pyruvate dehydrogenase,
-ketoglutarate dehydrogenase, and
cytochrome b2 are shown only for
MML266; similar results were ob-
served for MML235. Ten micrograms
of protein were loaded in each lane for
“Total” cell extracts and postmitochon-
drial supernatant (PMS) fractions, and
3 g were loaded for the mitochondrial
(Mito), intermembrane space, and ma-
trix fractions. (D) Sensitivity to mena-
dione in strains MML240 (GRX5),
MML100 (grx5), and MML290 (grx5-
8) growing exponentially at 30°C in
YPD medium. (E) Protein carbonyla-
tion in extracts from exponentially
growing MML240, MML100, and
MML290 cells in YPD medium at 30°C.
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guez-Manzaneque et al., 1999), and PSORT analysis predicts
no mitochondrial location for either Grx3 or Grx4.
We tested whether it was possible to detect a 3HA-tagged
version of Grx5 expressed under its own promoter. This
tagged form fully complemented all the grx5 mutant defects
in the MML240 strain, obtained after crossing the grx5 mu-
tant with a wild strain carrying an integrative plasmid with
the GRX5–3HA construction. A major form of the expected
mobility in Western blots was detected in extracts from
exponential cells grown on both glucose and glycerol (Fig-
ure 2B). A larger minor form was also observed, especially in
cells grown in YPD medium after menadione treatment.
Although this treatment did not up-regulate GRX5 expres-
sion (Rodrı´guez-Manzaneque et al., 1999), the total amount
of immunodetectable Grx5 protein almost doubled com-
pared with untreated cells (Figure 2B). This increase points
to some kind of posttranscriptional regulation of Grx5 levels
in oxidative conditions. We then used the tagged version of
Grx5 to determine its cellular location. Cell fractionation
studies demonstrated that wild-type Grx5 is located at the
mitochondria (Figure 2C). After causing outer membrane
disruption under hypotonic conditions, mitochondrial sub-
fractionation showed that Grx5 entirely colocalized with two
matrix lipoic acid-modified proteins, pyruvate dehydroge-
nase and -ketoglutarate dehydrogenase (Figure 2C). From
these results, we hypothesized that the deletion of a number
of amino acids at the N terminus would cause Grx5 to
remain at the cytoplasm. Two shorter forms of Grx5 were
constructed, one lacking the first eight amino acids (Grx5-
8) and the other lacking the first 23 residues (Grx5-23;
Figure 2A). We obtained the same results with both, al-
though here we only show results corresponding to the
eight-residue deletion. The shorter version of Grx5 remained
exclusively at the cytoplasm (Figure 2C), thus confirming
the importance of N terminus residues for adequate target-
ing of Grx5 at the mitochondria.
We then addressed the possibility that this version of
Grx5, present at the cytosol, could also protect cells against
oxidative stress. We therefore constructed a strain that pro-
duced only the cytosolic Grx5-8 version. This strain was
hypersensitive to menadione (Figure 2D) and showed con-
stitutive carbonylation levels even higher than those of cells
containing no Grx5 (Figure 2E). We conclude that Grx5 is
located in the mitochondria and that the abnormal presence
of Grx5 at the cytosol does not complement the phenotypes
that result from the absence of mitochondrial Grx5. The
moderately dominant negative effect of the grx5-8 allele
leaves open the possibility that the mutant protein interferes
with some cytosolic mechanism involved in oxidative stress
defense.
The Absence of Grx5 Causes Inactivation of
Mitochondrial Fe/S Enzymes
The defects associated with the absence of GRX5 are
common to mutants in mitochondrial proteins involved in
the biosynthesis/assembly of Fe/S clusters (Lill and Kis-
pal, 2000, and references therein). These defects and the
genetic interactions between GRX5 and genes responsible
for the biogenesis of Fe/S clusters led us to investigate the
involvement of Grx5 in the biogenesis and/or repair of
such clusters. We therefore measured the activity of mi-
tochondrial enzymes containing Fe/S clusters in a condi-
tional mutant in which GRX5 expression under the tet
promoter was doxycycline regulated. For this purpose,
the wild-type GRX5 allele was deleted and a tet-GRX5
construction was integrated at the LEU2 locus. The result-
ing strain (MML313) grew on glycerol in the absence of
doxycycline (GRX5 expressed), but upon addition of the
antibiotic (GRX5 transcription immediately repressed),
growth became arrested in 12 h. 4,6-Diamidino-2-phe-
nylindole staining confirmed that mitochondria retained
the DNA after 24 h of inhibition of GRX5 expression,
which is in accordance with a [rho] phenotype. The
activity of two mitochondrial enzymes with Fe/S clusters
(aconitase and succinate dehydrogenase) decreased dra-
matically when GRX5 was not expressed (15% activity
after 24 h; Figure 3A). In contrast, the activity of two
mitochondrial enzymes not depending on Fe/S clusters
(citrate synthase and malate dehydrogenase) remained
unchanged. Western blot analyses of aconitase and succi-
nate dehydrogenase demonstrated that the amounts of the
two proteins were not affected by inhibition of GRX5
expression (Figure 3B), indicating that the changes in
activity can be attributed to impairment of formation of
mature molecules.
The inhibition of Fe/S enzyme activities could give a
clue to the grx5 mutant growth defects in minimal SD
medium. When comparing growth of wild-type and grx5
cells in defined SC medium that lacked each of the 20
amino acids, we observed that grx5 cells were unable to
grow (or grew poorly) when deprived of leucine, lysine,
or glutamic acid (Figure 3C). However, the absence of any
other amino acid did not affect growth. The growth defect
was rescued when the mutant cells were transformed
with a centromeric plasmid expressing GRX5 (Rodrı´guez-
Manzaneque, Tamarit, Bellı´, Ros, and Herrero, unpub-
lished results). Thus, auxotrophy for these three amino
acids could explain defective growth of the mutant in
minimal medium. All three amino acids require Fe/S
enzymes for their biosynthesis. Glutamate biosynthesis
requires mitochondrial aconitase (Gangloff et al., 1990),
and the inactivation of this Fe/S enzyme also explains the
glutamate requirement of isa1 and isa2 mutants (Jensen
and Culotta, 2000). Lysine auxotrophy probably results
from the inactivation of the mitochondrial Fe/S enzyme
homoaconitase, which is involved in its synthesis (Bhat-
tacharjee, 1985; De Freitas et al., 2000). Lysine auxotrophy
also occurs in isa mutants (Jensen and Culotta, 2000).
Leucine biosynthesis requires the cytoplasmic Fe/S en-
zyme isopropyl malate isomerase, Leu1 (Kohlhaw, 1988).
Inactivation of this enzyme has been described for a num-
ber of mutants altered in the assembly of Fe/S cluster
proteins (Kispal et al., 1999; Kaut et al., 2000; Lange et al.,
2000). All of these data support the relationship between
the growth defects observed in grx5 cells in minimal
medium and the inactivation of Fe/S cluster-containing
enzymes implicated in amino acid biosynthesis.
Cells without Grx5 Are Not Defective in the
Holoforms of Heme-containing Proteins
Although heme groups and Fe/S clusters have different
biosynthetic pathways, both are also synthesized within the
mitochondria, require a source of reduced iron, and are
sensitive to oxidative stress (Kranz et al., 1998; Lange et al.,
Rodrı´guez-Manzaneque et al.
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1999). Heme deficiency in yeast has also been found associ-
ated with mutations such as atm1 (Kispal et al., 1997), jac1
(Voisine et al., 2001), and yfh1 (Foury, 1999), although this
could be the result of alterations in iron homeostasis. There-
fore, we analyzed the presence of the mature form of cyto-
chrome c in cell extracts from MML313 cells (tetO7-GRX5)
grown in YPG medium before and after the addition of
doxycycline. Holo-cytochrome c was detected through the
peroxidase activity displayed by the heme groups. The con-
tent of holo-cytochrome c did not decrease even after 48 h of
repression of GRX5 expression (Figure 4). Although cyto-
chrome c is rather stable in normal growth conditions (half-
life of 7 h [Pearce and Sherman, 1995]), a moderate to
strong effect of Grx5 absence on heme synthesis would have
been detected during the time course of the experiment.
Thus, Grx5 is not essential for the biosynthesis of heme-
containing proteins in mitochondria.
Iron Accumulates in the Cells in the Absence of Grx5
We next analyzed whether, as with other mutants in Fe/S
cluster biogenesis, the absence of Grx5 caused iron accumu-
lation in the cells. In the grx5 mutant growing exponentially
in YPD medium, an almost sixfold increase in total cell iron
was observed with respect to wild-type cells (Figure 5A).
This was paralleled by a decrease in aconitase activity but
not in the activity of the non-Fe/S enzyme citrate synthase
(Figure 5A). Inhibition of aconitase in the grx5 cells grown
on glucose was not as dramatic as that observed in cells
conditionally expressing GRX5 on glycerol (Figure 3A). The
iron accumulation was attributable to the absence of Grx5. In
fact, in MML313 (tetO7-GRX5) cells cultured in YPG medium
under the same conditions as in Figure 3A, inhibition of
GRX5 expression by doxycycline induced iron accumulation
in the cell (Figure 5B).
A yeast frataxin mutant (yfh1) preferentially accumulates
iron at the mitochondria, whereas cytosolic iron becomes
depleted (Babcock et al., 1997; Radisky et al., 1999). On the
contrary, when non-GRX5–expressing cells were subfrac-
tionated into mitochondrial and postmitochondrial frac-
tions, iron was shown to hyperaccumulate in both fractions
(Figure 5C). Control analyses showed that the postmito-
chondrial fraction was not contaminated by mitochondrial
enzymes (citrate synthase and -ketoglutarate dehydroge-
nase; Rodrı´guez-Manzaneque, Tamarit, Bellı´, Ros, and Her-
rero, unpublished results). Under our conditions, mitochon-
drial iron represents 23–28% of total cell iron in both the
absence and presence of GRX5 expression (as calculated
from the data in Figure 5C).
Inactivation of Fe/S Enzymes in the Absence of Grx5
Is Not a Consequence of Iron Accumulation in the Cell
Grx5 could be directly responsible for maintaining iron ho-
meostasis. In that case, inactivation of Fe/S enzymes in grx5
cells could be caused by the generation of ROS due to the
presence of high levels of iron. Alternatively, Grx5 could be
directly implicated in the biogenesis of Fe/S-protein com-
plexes. In the latter case, increased iron levels in both cytosol
and mitochondria would be a consequence of impairment of
the formation of such complexes in the absence of the glu-
taredoxin. We used two approaches to test the direct in-
volvement of Grx5 in Fe/S-enzyme biogenesis indepen-
dently of the iron levels existing in the cell. First, we used the
iron chelator BPS to create conditions in which internal iron
levels in grx5 cells were similar to those in wild-type cells. In
such conditions, aconitase activity remained greatly dimin-
ished in the mutant, in contrast to the non-Fe/S enzyme
malate dehydrogenase (Figure 6A). It should be noted that,
Figure 3. Lack of Grx5 nega-
tively affects Fe/S enzyme activ-
ity. (A) MML313 cells growing ex-
ponentially in YPG medium at
30°C (1  107 cells/ml) were
added at time 0 with doxycycline
(2 g/ml) to inhibit GRX5 expres-
sion. Enzyme activity in cell ex-
tracts was determined at the indi-
cated times. (B) Western blot
analysis of aconitase (Aco1) and
succinate dehydrogenase (Sdh2)
in the same samples as in A. (C)
Growth of wild-type CML235 and
mutant MML19 (grx5) cells con-
taining the integrative LEU2 plas-
mid YIplac128 (Gietz and Sugino,
1988) in SC medium with all the
supplements or deprived of
leucine, lysine, or glutamic acid.
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in this particular genetic background, reduction of aconitase
activity in grx5 cells compared with wild-type cells is even
higher than in the W303 background in the same growth
conditions (compare Figures 6A and 5A).
Second, based on the fact that Aft1 is a transcriptional
factor involved in the expression of genes responsible for the
high-affinity iron transport system (Yamaguchi-Iwai et al.,
1995; Casas et al., 1997), we constructed a single aft1 and a
double aft1 grx5 mutant. As expected, aft1 cells had reduced
intracellular iron levels, and, probably as a consequence of
this, activity of iron-dependent enzymes such as aconitase
was also reduced (Figure 6B). The absence of Grx5 did not
lead to iron accumulation in the aft1 grx5 cells, indicating
that increased levels of the metal in grx5 cells requires Aft1-
dependent iron transport. Importantly, the double mutant
displayed additional reduction of aconitase activity com-
pared with aft1 cells, in conditions where intracellular iron
remained low (Figure 6B), thus confirming that the primary
consequence of the absence of Grx5 is not the accumulation
of iron.
Modification of the Intracellular Redox Potential
Does Not Suppress the grx5 Growth Defects
Glutaredoxins have been assigned a role as general reduc-
tants of disulfide bonds in cell proteins (Prinz et al., 1997;
Carmel-Harel and Storz, 2000). In E. coli, inactivation of the
glutaredoxin and/or thioredoxin systems alters the thiol-
disulfide equilibrium, which can be reversed in anaerobic
conditions or by external reductants such as dithiothreitol
(DTT; Prinz et al., 1997). We hypothesized that the growth
defects in the absence of Grx5 could be caused by the alter-
ation of the redox potential at the mitochondria and, conse-
quently, by the inhibition of oxidation-sensitive Fe/S-con-
taining proteins. To address this problem, wild-type and
grx5 cells were cultured in SD minimal medium in anaerobic
conditions, a situation that should compensate, at least in
part, for the effect of the grx5 mutation on the thiol-disulfide
equilibrium. However, the mutant was unable to grow on
SD plates in anaerobiosis (Figure 7A). While growing in
anaerobiosis in SC medium, grx5 cells still accumulated high
Figure 4. Effect of Grx5 depletion on the amount of heme co-
valently bound to cytochrome c. Expression of GRX5 was inter-
rupted (time 0) by the addition of doxycycline (2 g/ml) to
MML313 cells growing exponentially in YPG medium at 30°C.
Proteins from whole cell lysates (samples taken at the indicated
times after antibiotic addition) were separated by nonreducing SDS-
PAGE, blotted onto a polyvinylidene difluoride membrane, and
analyzed for heme-carrying proteins. In these conditions, heme
bound to cytochrome c was the most prominent band detected
(marked with an arrow). As a standard, 0.1 g of cytochrome c from
bovine heart was loaded on the left-most line.
Figure 5. Iron accumulates in the cell in the absence of Grx5. (A)
W303–1A (wt) and MML100 (grx5) cells were grown exponentially
in YPD medium at 30°C to determine iron concentration in the cell
and also aconitase and citrate synthase activities in total cell ex-
tracts. (B) MML313 cells growing exponentially in YPG medium at
30°C were added (time 0) with doxycycline (2 g/ml), and total cell
iron concentration was determined at different intervals after anti-
biotic addition. (C) Distribution of iron (relative to total protein in
the fraction) between postmitochondrial fraction (PMF) and mito-
chondria (Mito), in MML313 cells untreated (doxy) or treated for
24 h with doxycycline at 2 g/ml (doxy).
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amounts of iron compared with wild-type cells (Figure 7A).
As a second approach, cells were cultured on SD plates to
which with different amounts of DTT were added, in con-
ditions where this reductant has been shown to be active on
yeast cells in vivo (Holst et al., 1997). DTT was unable to
suppress the growth defects of the grx5 mutant at concen-
trations up to 4 mM (Figure 7B). Higher DTT concentrations
were partially inhibitory of growth of wild-type cells in SD
medium, whereas in complete medium grx5 cells did not
show higher sensitivity to DTT than wild-type cells (Rodrı´-
guez-Manzaneque, Tamarit, Bellı´, Ros, and Herrero, unpub-
lished results). We conclude that the grx5 defective growth is
not primarily due to the alteration of the intracellular redox
potential, thus supporting the direct participation of Grx5
glutaredoxin in Fe/S cluster biogenesis.
DISCUSSION
Yeast cells contain both dithiol (Grx1, Grx2) and monothiol
(Grx3, Grx4, Grx5) glutaredoxins. The two types of glutare-
doxins coexist in many species from bacteria to humans
(Rodrı´guez-Manzaneque et al., 1999), but specific roles for
monothiol glutaredoxins have not previously been estab-
lished. Grx5 is the yeast glutaredoxin whose absence causes
the most dramatic effects on the oxidative damage to cell
proteins, sensitivity to external oxidants, and general
growth defects (Rodrı´guez-Manzaneque et al., 1999). We
have shown that Grx5 is located at the mitochondrial matrix
and that its absence has a negative effect on the activity of
mitochondrial proteins with Fe/S clusters but not on heme-
containing proteins. Mitochondrial matrix location has also
been demonstrated for other proteins that participate in
Fe/S center protein assembly (reviewed by Lill and Kispal,
2000). The functional relationship between Grx5 and Fe/S
cluster assembly was confirmed by the fact that overexpres-
sion of genes participating in Fe/S cluster assembly partially
suppressed various grx5 cell phenotypes. Of those, SSQ1
codes for a Hsp70-type chaperone that might stabilize apo-
proteins for Fe/S cluster coordination (Lill and Kispal, 2000)
or even participate directly in the recognition/transfer step
of clusters from Isu proteins to receptor polypeptides (Sil-
berg et al., 2001). The other partial suppressor of grx5 mu-
tants is ISA2. IscA, its product homologue in E. coli, com-
plexes with ferrodoxin to transfer iron and sulfide to form
[2Fe-2S]-ferrodoxin (Ollagnier-de-Choudens et al., 2001).
The fact that ferrodoxin is also a component of the Fe/S
cluster synthesis machinery in yeast suggests the hypothesis
that multiprotein complexes form part of such a machinery.
The function of Grx5 in the assembly of Fe/S centers is not
apparently related to that proposed for the human homo-
logue PICOT, which would regulate signaling through the
protein kinase C pathway (Isakov et al., 2000; Witte et al.,
2000). Although Grx5 contains the PICOT homology do-
main, it lacks the N-terminal extension (with a thioredoxin
or glutaredoxin-like module) present in Grx3 and Grx4 and
also in other members of the PICOT superfamily (Isakov et
al., 2000). This, coupled with the differential compartmental-
ization, supports the hypothesis that the PICOT domain
could be shared by various oxidoreductases, which contain
a CKSF motif in the domain (Rodrı´guez-Manzaneque et al.,
1999) but serve different biological functions.
Besides the inactivation of enzymes with Fe/S clusters
such as aconitase or succinate dehydrogenase, mutants de-
ficient in GRX5 share a number of phenotypes with others
affected in the Fe/S cluster synthesis. These deficiencies
include inability to grow in respiratory conditions and iron
accumulation in their mitochondria. The last of these may be
responsible for the oxidative damage observed in various
cellular macromolecules when Fe/S cluster assembly is dis-
rupted because of iron-mediated ROS formation. We ob-
served additive effects on growth rate and on protein oxi-
dative damage between mutants in GRX5 and in other
glutaredoxin genes (Rodrı´guez-Manzaneque et al., 1999) and
also between grx5 and sod1 mutations (Rodrı´guez-Manza-
neque, Tamarit, Bellı´, Ros, and Herrero, unpublished obser-
vations). This could be the consequence of the inability to
repair iron-mediated macromolecular damage (both in mi-
tochondria and cytosol) in Grx5-depleted cells in the absence
of other glutaredoxins or of cytosolic superoxide dismutase.
In either case, compartmentalization studies and sequence
analysis indicate that Grx5 is the only dithiol plus monothiol
glutaredoxin that is mitochondrially located and suggests
that it does not directly share functions with Grx1–4. Inabil-
Figure 6. Activity of Fe/S enzymes is inhibited in grx5 cells inde-
pendently of intracellular iron concentration. (A) CML235 (wt) or
MML19 (grx5) cells were grown exponentially in YPD medium
(also in the presence of 80 M BPS in the case of MML19 cells), and
total cellular iron concentration and aconitase and malate dehydro-
genase activity were determined. (B) The same parameters as in A
were determined in exponential YPD cultures at 30°C of W303–1A
(wt), MML100 (grx5), MML348 (aft1), and MML345 (grx5 aft1)
cells.
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ity to suppress grx5 defects in conditions of GRX3/4 overex-
pression confirms this suggestion. Similarly, a double grx5
trx3 mutant is no more sensitive to oxidants or growth
defects than a single grx5 mutant (Rodrı´guez-Manzaneque,
Tamarit, Bellı´, Ros, and Herrero, unpublished observations),
thus arguing in favor of completely separate functions for
Grx5 and the mitochondrial Trx3 thioredoxin. However, the
relatively mild phenotypes of grx5 cells compared with
some other mutants in Fe/S cluster synthesis point to partial
functional redundancy between Grx5 and other thiol oxi-
doreductases in the cell.
In Grx5-deficient cells, iron accumulation occurs at similar
levels in mitochondria and extramitochondrial fractions,
whereas in frataxin mutants iron accumulates exclusively at
the mitochondria at the expense of cytosolic iron (Babcock et
al., 1997; Foury and Cazzalini, 1997; Radisky et al., 1999).
Although these differences argue against Grx5 acting in
parallel with Yfh1 frataxin in the maintenance of iron ho-
meostasis in the cell, it was still possible that extensive iron
accumulation in grx5 cells was a direct consequence of the
absence of Grx5. Consequently, alterations in Fe/S enzyme
activity could have been the result of the sensitivity of Fe/S
clusters to high levels of ROS generated at increased iron
concentrations. However, we can discard this possibility
because the reduction of intracellular iron levels to almost
normal or even lower than normal concentrations does not
suppress the inactivation of Fe/S enzymes in grx5 cells.
Similar conclusions have been reached for Jac1 function
(Voisine et al., 2001). These facts, together with the inability
to suppress the grx5 growth phenotypes in anaerobiosis or
by the addition of external reductants, support a direct
participation of Grx5 in Fe/S cluster assembly. The question
remains as to whether the disruption of Fe/S cluster assem-
bly could cause such high levels of mitochondrial iron and,
in the case of grx5 cells, cytosolic iron. Although the process
of iron transport across the cytoplasmic membrane of yeast
cells has been elucidated (Askwith and Kaplan, 1998; Eide,
1998), the mechanism of iron entry into the mitochondria
remains uncertain (Lange et al., 1999). A protein containing
Fe/S clusters might participate in the regulation of mito-
chondrial iron assimilation, perhaps acting as an iron sensor
that could act upstream of the nuclear transcription factor
Aft1. This would explain the high levels of this metal found
at the mitochondria in the absence of normal Fe/S cluster
assembly at the organelle.
Although knowledge of the gene products involved in the
maturation of Fe/S proteins at the yeast mitochondria has
improved in recent years, the specific role of individual
proteins and the biochemistry of the process remain obscure.
Assembly of Fe/S centers in the apoprotein requires reduc-
tion of disulfide bridges between cysteine residues for coor-
dination of Fe atoms (Beinert et al., 1997). In the case of SoxR
(a transcriptional regulator of E. coli involved in oxidative
stress response whose activity depends on the redox state of
a Fe/S cluster present in it [Hidalgo et al., 1997]), GSH
reductase and thioredoxins are required for the in vivo
Figure 7. Growth of grx5 cells is affected in anaerobiosis or in the presence of external
reductants. (A) CML235 (wt) and MML19 (grx5) cells were grown exponentially in SC
liquid medium at 30°C to exponential phase, in anaerobic or aerobic conditions, and total
iron concentration in the cell was determined (top). The same strains were inoculated on SD
agar plates, and growth was recorded after 3 d ( O2) or 4 d (O2) of incubation at 30°C.
(B) CML235 (wt) and MML19 (grx5) cells were inoculated on SD agar plates containing
different DTT concentrations, and growth was recorded after 3 d (wt) or 4 d (grx5) of
incubation at 30°C.
Rodrı´guez-Manzaneque et al.
Molecular Biology of the Cell1118
response of SoxR to oxidants (Ding and Demple, 1998). Grx5
could play a similar role in yeast mitochondria, although in
this case a monothiol mechanism for disulfide bridge reduc-
tion should be postulated. This would require a mixed di-
sulfide intermediary between one of the cysteine residues
and GSH that would be attacked by the monothiol glutare-
doxin (Bushweller et al., 1992). A variant of this hypothesis
may be formulated from the observation that GSH and other
monothiols are able to disassemble Fe/S clusters through
GSH-derived reactive free radicals. The latter could form
inactivating mixed disulfides with the cysteine residues re-
sponsible for iron chelation (Ding and Demple, 1996). Grx5
could be required to repair such toxic disulfides, therefore
restoring the ability to assemble the clusters on the sulfhy-
dryl groups of the apoproteins. Finally, Grx5 could play a
role during the Nfs1-catalized desulfuration of cysteine. This
reaction has been studied in the Azotobacter vinelandii homo-
logue NiFS and involves formation of a persulfide between
sulfur and Cys329 of NiFS (Zheng et al., 1994). In yeast, Grx5
could be involved in the cleavage of this persulfide, leading
to the release of sulfur and regeneration of reduced Nfs1.
More studies are needed to determine the biochemical role
of Grx5 in the formation of Fe/S clusters and to confirm
whether Grx5 is part of a mitochondrial matrix multiprotein
complex responsible for such a process.
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